Products
17085 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Newmont Constant Leverage with ISIN code: CH1290992911 | Newmont | Constant Leverage | Long | ― | 53.128 | 43.1 | 0.260 | 43.36 | 1 | -0.32 % | 10.77 % | 66.60 % | 16 Feb. 2024 | |
Nike Constant Leverage with ISIN code: CH1362349826 | Nike | Constant Leverage | Long | ― | 83.428 | 14.57 | 0.170 | 14.74 | 1 | 0.62 % | -7.43 % | 62.79 % | 9 Jul. 2024 | |
Nike Constant Leverage with ISIN code: CH1119067986 | Nike | Constant Leverage | Long | ― | 83.428 | 0.19 | 0.020 | 0.21 | 1 | -5.00 % | -9.52 % | 26.67 % | 12 May. 2022 | |
Nike Constant Leverage with ISIN code: CH1362349834 | Nike | Constant Leverage | Long | ― | 83.428 | 15.73 | 0.250 | 15.98 | 1 | 0.70 % | -10.88 % | 82.27 % | 9 Jul. 2024 | |
Nike Constant Leverage with ISIN code: CH1362350402 | Nike | Constant Leverage | Long | ― | 83.428 | 12.78 | 0.100 | 12.88 | 1 | 0.55 % | -4.41 % | ― | 12 Aug. 2024 | |
Nokia Constant Leverage with ISIN code: CH1235293177 | Nokia | Constant Leverage | Long | ― | 3.977 | 0.32 | 0.010 | 0.33 | 1 | -5.88 % | 33.33 % | 45.45 % | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 3.977 | 1.06 | 0.010 | 1.07 | 1 | -3.64 % | 23.26 % | 32.50 % | 6 May. 2022 | |
Novartis Constant Leverage with ISIN code: CH1346746238 | Novartis | Constant Leverage | Long | ― | 102.1 | 15.55 | 0.050 | 15.6 | 1 | 0.65 % | 6.87 % | 13.09 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746246 | Novartis | Constant Leverage | Long | ― | 102.1 | 18.2 | 0.100 | 18.3 | 1 | 1.11 % | 10.98 % | 17.80 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 102.1 | 14.25 | 0.060 | 14.31 | 1 | 1.64 % | 7.87 % | 14.18 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 102.1 | 10.9 | 0.110 | 11.01 | 1 | 4.01 % | 20.58 % | 25.14 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1346746253 | Novartis | Constant Leverage | Long | ― | 102.1 | 20.35 | 0.150 | 20.5 | 1 | 1.50 % | 14.33 % | 20.77 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 102.1 | 14.52 | 0.090 | 14.61 | 1 | 2.47 % | 12.04 % | 19.41 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 102.1 | 13.32 | 0.100 | 13.42 | 1 | 3.34 % | 16.33 % | 23.33 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 931.132 | 20.03 | 0.080 | 20.11 | 1 | 2.67 % | 6.09 % | 2.77 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587347 | Novo Nordisk | Constant Leverage | Long | ― | 931.132 | 15.82 | 0.090 | 15.91 | 1 | 3.87 % | 9.25 % | -7.49 % | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1346000271 | Novo Nordisk | Constant Leverage | Long | ― | 931.132 | 8.37 | 0.030 | 8.4 | 1 | 2.70 % | 6.08 % | 2.83 % | 9 Jul. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 931.132 | 0.19 | 0.010 | 0.2 | 1 | 0.00 % | 11.76 % | -89.20 % | 23 Feb. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 931.132 | 6.72 | 0.040 | 6.76 | 1 | 4.02 % | 9.45 % | -7.44 % | 11 Mar. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993026 | Novo Nordisk | Constant Leverage | Long | ― | 931.132 | 4.52 | 0.030 | 4.55 | 1 | 5.12 % | 12.16 % | -25.04 % | 23 Feb. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.